Surgeon-designed 3D AI technology delivers fully customized, physician-validated pre-consultation intelligence — already used by top U.S. practices, with 320 patients served in the platform's first two months
-- MDConsult AI today announced the commercial launch of its pre-consultation software platform, purpose-built for cataract and refractive surgeons and their patients. Since going live in May 2026, MDConsult AI has been adopted by a beta cohort of leading U.S. ophthalmology practices, completing consultations for 320 patients by early July, with adoption continuing to grow.
Unlike general-purpose AI tools being repurposed for healthcare, MDConsult AI is built on what the company calls 3D AI— a foundationally different architecture engineered specifically for the complexity of ophthalmic surgical decision-making. At the core of the platform is a proprietary approach the company terms deep directed discovery a fully customizable framework that allows each surgeon to configure their own algorithms and clinical settings so the software mirrors exactly how they practice medicine.
The result is a system of effectively infinite configurability. By the time a patient engages with the AI, it is already operating on surgeon-validated, pre-contextualized intelligence — understanding who the patient is and how that specific surgeon would counsel them, long before a human conversation begins.
Solving a Widening Gap in the IOL Market
MDConsult AI was created to address a set of converging pressures in cataract and refractive surgery: rapid, complex innovation in the intraocular lens (IOL) market; declining physician reimbursement and shrinking consultation time; a persistent gap in patient education and understanding; and growing demand across practices to streamline the surgical consultation process without sacrificing quality of care.
"Patients today are being asked to make increasingly sophisticated lens and procedure decisions in less time than ever, with physicians under more reimbursement pressure than ever," said Gary Wortz, MD co-founder of MDConsult AI. "We didn't want another generic chatbot layered on top of that problem. We built a system that thinks the way each surgeon actually practices — because no two surgeons counsel patients exactly the same way, and patients deserve consultations that reflect that."
Early Results: Less Chair Time, Better-Prepared Patients
In early deployment across its beta practices, MDConsult AI has demonstrated measurable impact on the consultation experience, including:
- Reduced chair time for physicians and staff
- Improved patient education and patient readiness heading into the surgical consultation
- A more streamlined consultation workflow overall
- Increased advanced-technology conversion rates in some practices
"Our beta users are some of the top cataract and refractive practices in the country, and the early data is validating exactly what we set out to build," said Tamara Bogetti, MBA, co-founder and co-manager of MDConsult AI. "We're seeing practices get real efficiency gains while patients walk into their surgical consultation more informed and more confident. That combination — efficiency and better patient experience — is very hard to achieve at the same time, and it's the reason we built this."
Beta users are already reporting a noticeable shift in both consultation length and patient engagement.
"You can tell if the patient has done the MDConsult survey. Patients are more informed and have an idea of what they want," said Dr. Jon Solomon, a beta user of MDConsult AI. "My consult time has reduced by 40-50% with those patients."
"Patients are asking about lenses and starting off conversations in a much more targeted way," said Dr. Sarah Griffin a beta user of MDConsult AI. "I love reviewing the transcript and seeing the types of questions the patients are asking in the AI chat."
MDConsult AI is offered to practices as a monthly subscription, positioning it as an accessible operational tool rather than a large capital investment.
Built by Surgeons, Commercialized by Industry Veterans
MDConsult AI was designed by two high-volume cataract and refractive surgeons with hands-on AI expertise and commercialized alongside two ophthalmology industry veterans. The founding team includes:
Gary Wortz, MD** — Co-Founder, Co-Manager
Tamara Bogetti, MBA** — Co-Founder, Co-Manager
Joaquin De Rojas, MD** — Co-Founder
Ranna Jaraha** — Co-Founder
The team's combined depth in clinical ophthalmology, AI development, and industry commercialization has positioned MDConsult AI as a trusted, practice-aligned partner for surgeons navigating an increasingly complex technology and reimbursement landscape.
What's Next
MDConsult AI has commercialized first in the cataract surgery market. The company plans to expand into additional areas of ophthalmology, and ultimately into other specialties of medicine where patient education is complex and practice efficiency demands are high — bringing the same surgeon-directed, deep directed discovery approach to a broader set of clinical settings.
About MDConsult AI
MDConsult AI is a highly customized, deep directed discovery AI pre-consultation platform built for cataract and refractive surgeons and their patients. Powered by proprietary 3D AI technology, MDConsult AI allows surgeons to fully configure clinical algorithms to match their individual practice patterns, delivering surgeon-validated, pre-contextualized patient intelligence ahead of the surgical consultation. Founded by a team of practicing surgeons and ophthalmology industry veterans, MDConsult AI is used by leading practices across the United States.
Contact Info:
Name: Gary Wortz
Email: Send Email
Organization: MDConsult.AI
Website: http://MDconsult.ai
Release ID: 89198403
In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.
